From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

BNP Level Predicts Mortality in Acute Decompensated Heart Failure

The association is linear and independent of left ventricular ejection fraction.

The Acute Decompensated Heart Failure National Registry is a prospective database of patient information beginning with the initial point of care, either in the hospital or emergency department, and continuing until patient discharge, transfer, or death. Researchers retrospectively evaluated this data to determine if admission B-type natriuretic peptide (BNP) level predicted in-hospital mortality in patients with acute decompensated heart failure.

The 48,629 BNP measurements obtained within 24 hours of presentation were divided into quartiles: Q1 (<430 pg/mL), Q2 (430–839 pg/mL), Q3 (840–1729 pg/mL), and Q4 (≥1730 pg/mL). Mortality rate increased linearly with increasing BNP level. Depending on adjustments made in the analyses, the odds ratio for death was 2.23 to 3.17 times higher in patients with admission BNP levels in Q4 as compared to Q1. The association between mortality and BNP level persisted independent of left ventricular ejection fraction (LVEF), new-onset acute heart failure, or acute decompensation of chronic heart failure. BNP levels also predicted need for mechanical ventilation, length of hospital stay, intensive care unit admission, need for cardiopulmonary resuscitation requirements, and symptoms at discharge.

Comment: These authors demonstrate that BNP level is an effective risk-assessment tool for mortality and multiple complications arising from acute decompensated heart failure. The biomarker predicted morbidity and mortality even in patients with LVEF <15%, who would be expected to have chronically elevated BNP. In addition, higher BNP was associated with lower LVEF. Further research may lead us to use BNP as the "troponin of heart failure," with elevated levels portending a worse prognosis, regardless of other clinical findings. This study provides helpful information in an area that currently has little evidence-based direction regarding patient management.

— Tiffany M. Osborn, MD

Published in Journal Watch Emergency Medicine June 1, 2007

Citation(s):

Fonarow GC et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007 May 15; 49:1943-50.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.